Description
The global mammography systems market was valued at USD 3.6 billion in 2025 and is projected to reach USD 5.9 billion by 2032, registering a CAGR of 7.3% during the forecast period. Mammography systems are specialized breast imaging devices used for the early detection, diagnosis, and monitoring of breast cancer. Continuous technological advancements in digital mammography, digital breast tomosynthesis (3D mammography), artificial intelligence-assisted image analysis, and contrast-enhanced mammography are transforming breast cancer screening and diagnostic workflows. The increasing prevalence of breast cancer, expansion of national screening programs, and growing awareness regarding early diagnosis remain the primary factors driving market growth.
Market growth is further supported by increasing investments in healthcare infrastructure, favorable reimbursement policies in developed economies, and rising adoption of AI-enabled imaging platforms that improve diagnostic accuracy and workflow efficiency. Healthcare providers are increasingly replacing conventional analog systems with advanced digital mammography platforms that offer enhanced image quality, lower radiation exposure, and faster examination times. In addition, the growing establishment of breast imaging centers, mobile screening units, and government-led awareness campaigns continues to expand market opportunities. North America dominates the global market owing to widespread screening adoption and technological leadership, while Asia Pacific is expected to register the fastest growth due to improving healthcare infrastructure and increasing breast cancer screening initiatives.
Key Highlights of the Report
• By product, full-field digital mammography (FFDM) systems dominate the global mammography systems market, owing to superior image quality, improved diagnostic accuracy, and widespread adoption across hospitals and diagnostic imaging centers.
• Digital breast tomosynthesis (DBT) systems are expected to witness the fastest growth, driven by increasing preference for three-dimensional breast imaging and improved detection of early-stage breast cancers.
• Analog mammography systems continue to maintain demand in selected emerging markets, supported by lower acquisition costs and gradual healthcare infrastructure modernization.
• By technology, 3D mammography accounts for a rapidly growing market share, reflecting increasing clinical adoption for breast cancer screening and diagnostic evaluation.
• Computer-aided detection (CAD) and AI-assisted imaging solutions continue to gain traction, enabling radiologists to improve lesion detection, reduce interpretation time, and enhance diagnostic confidence.
• By modality, non-portable mammography systems dominate the market, owing to their widespread installation in hospitals, diagnostic centers, and dedicated breast imaging facilities.
• Portable mammography systems are projected to register significant growth, supported by increasing deployment in rural healthcare programs, mobile screening units, and community-based breast cancer awareness initiatives.
• By end use, hospitals account for the largest market share, driven by high patient volumes, comprehensive diagnostic capabilities, and availability of advanced breast imaging technologies.
• Diagnostic imaging centers are expected to witness substantial growth, supported by increasing outpatient imaging services, specialized breast care programs, and rising demand for preventive screening.
• The increasing global incidence of breast cancer remains one of the primary market drivers, encouraging governments and healthcare organizations to expand population-wide breast screening initiatives.
• Technological advancements in digital mammography, tomosynthesis, contrast-enhanced imaging, and artificial intelligence are transforming breast imaging, improving diagnostic precision while reducing unnecessary biopsies and recall rates.
• Growing awareness regarding early breast cancer detection continues to accelerate market growth, supported by national screening programs and public health campaigns worldwide.
• North America dominates the global mammography systems market, supported by strong reimbursement policies, advanced imaging infrastructure, widespread adoption of digital technologies, and high breast cancer screening participation.
• Asia Pacific is anticipated to witness the fastest growth, driven by expanding healthcare infrastructure, increasing healthcare expenditure, improving access to diagnostic imaging, and rising breast cancer awareness.
• The competitive landscape is moderately consolidated, with leading manufacturers focusing on AI-enabled breast imaging platforms, digital breast tomosynthesis, workflow automation, strategic collaborations, and product innovation to strengthen their market presence.
Key Company Profiles
• Analogic
• Hologic
• Canon Medical
• Delphinus Medical Technologies
• GE HealthCare
• IMS Giotto
• Neusoft Medical Systems
• Philips
• Siemens Healthineers
• United Imaging Healthcare
Data Source
Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise.
